Obesity May - QuikReader

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by ...

Health - ABC News - 8 hours ago

Three-Quarters of U.S. Adults Are Now Overweight or Obese

A sweeping new paper reveals the dramatic rise of obesity rates nationwide since 1990.

Top stories - The New York Times - November 15

Biden proposes Medicare, Medicaid coverage of obesity drugs

The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be covered under Medicaid and Medicare for more Americans. Millions of Americans ...

Politics - The Hill - 18 hours ago

Biden proposes anti-obesity drug rule

Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Biden proposes Medicaid, Medicare cover obesity drugs A proposed rule from the Biden administration would ...

Politics - The Hill - 12 hours ago

Semaglutide linked to reduced arthritis knee pain in people with obesity, study finds

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds.

Novo Nordisk's obesity-fighting drugs fatten Denmark's economy

Danish company Novo Nordisk has a market cap larger than the entire country's GDP. As it grows, it's having an impact on other industries.

Almost 3 in 4 US adults overweight or obese: Research

Nearly three-quarters of U.S. adults are considered overweight or obese, according to new research published Thursday from The Lancet. The research points to a substantial increase in overweight ...

Politics - The Hill - November 15

'I thought I'd die after injecting black market anti-obesity drug'

Paige Roberts was left needing hospital treatment after injections made her vomit for 48 hours.

Even with access to blockbuster obesity drugs, some people don't lose weight

Most people taking popular drugs like Ozempic and Wegovy to lose weight have shed significant pounds

Health - ABC News - 3 days ago

Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal

The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.

Top stories - The New York Times - 16 hours ago

Biden proposes Medicare and Medicaid cover weight-loss drugs for obese Americans

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday ...

Health - ABC News - 15 hours ago

Biden proposes expanding obesity drug coverage under Medicare and Medicaid

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.

How we're thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS

Robert F. Kennedy Jr. has been a vocal critic of obesity drugs belonging to the fast-growing GLP-1 class.

Business - CNBC - November 15

Fat ‘remembering’ past obesity drives yo-yo diet effect, say experts

Research shows fat cells are affected by obesity in a way that alters how they respond to food, potentially for years. Losing weight can be a frustrating game: after months of successful slimming, ...

World - The Guardian - November 18

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

Business - CNBC - 14 hours ago

New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows

The drug, which is named MariTide and delivered in a monthly injection, is some time away from being sold.

Business - The New York Times - 16 hours ago

Doctor says Biden's weight-loss drug proposal is a "formal recognition" that obesity is an illness

The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare and Medicaid. CBS News medical contributor Dr. Celine Gounder discusses ...

To Whom It May Concern

Some tips for whoever ends up winning.

Top stories - The New York Times - November 6

Jerry: 'Not crazy' Cowboys could keep McCarthy

Mike McCarthy's future as Dallas' coach has been a seasonlong question, but Jerry Jones said it's "not crazy" to think McCarthy could get a contract extension.

Sports - ESPN - 17 hours ago

An Israel-Hizbollah ceasefire may not be the end

Benjamin Netanyahu’s confidence risks hubris, while the militant group will already be plotting its rehabilitation

Business - Financial Times - 13 hours ago

Badenoch says she may need a softer approach

The Tory leadership frontrunner admits she may need to "calibrate" her approach, see by some as combative.

Foreign Election Interference, and Volkswagen May Close Factories

Plus, why you should never cross a crow.

Top stories - The New York Times - October 29

Panthers to start Young; Brooks may make debut

The Panthers will again start Bryce Young at quarterback Sunday, while rookie running back Jonathon Brooks could make his NFL debut vs. the Saints.

Sports - ESPN - October 31

England's last executed 'witch' may have survived

A spelling error in a court document could mean the woman was not hanged, a Southampton historian says.

Jobless claims retreat for third straight week, hit lowest level since May

Initial jobless claims fell by 12,000 to 216,000 in the week ending Oct. 26, compared with economists’ expectations that claims would rise to 230,000.

Business - MarketWatch - October 31

The Jobs Report on Friday May Be a Fluke and a Political Football

Economists expect the October data to show unusually weak job creation. But hurricanes and strikes may account for much of the shortfall.

Business - The New York Times - October 31

How the US election may unsettle Europe

Europeans mostly prefer Harris to Trump but challenges lie ahead on democracy, defence and economics

World - Financial Times - November 2

The Best Ever Game Controller May Be Set for a Comeback

The GameCube's controller remains a titan, which is why so many have “borrowed” from its design. But now things are afoot that signal Nintendo could be about to resurrect this gaming gem.

Tech - Wired - November 3

Watchdog says cladding removal deadline may be missed

It says up to 60% of buildings with dangerous cladding have still not been identified.

You May Not Be Able to Outrun a Vampire Bat

Scientists put the bloodsucking mammals on a treadmill to understand how they get the energy to chase down their next meal.

Science - The New York Times - November 7

With Trump Win, Musk’s Mars Dream May Advance

After bold, even overly ambitious comments about reaching the red planet, the billionaire founder of SpaceX may be positioned for added government support.

Business - Inc. - November 8

Assisted dying: caution and compromise may end in dissatisfaction

Politicians who support a law change in principle may still vote against the bill that currently falls short

World - Financial Times - November 12

At Long Last, the Surge in S.T.I.s May Be Leveling Off

Rates of gonorrhea declined in 2023, while diagnoses of syphilis and chlamydia held roughly steady, according to new C.D.C. data.

Health - The New York Times - November 12

The Trump majority may soon feel buyers’ remorse

The 2024 election results suggest that the Trump majority may soon have cause for second thoughts, as the proposed tax cuts and tariffs could lead to increased inflation and worker shortages, ...

Politics - The Hill - November 13

Trump needs concessions from Putin — they may be forthcoming

The Russian president wants to save face on Ukraine but this doesn’t mean he won’t give anything away

World - Financial Times - November 14

Latest in Obesity May